Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CSS20020042	注射用新型重组人肿瘤坏死因子		Lyophilized	Biological Products(1)	New Drug Application	2002-08-13	中国人民解放军第四军医大学生物技术中心上海赛达生物药业有限公司广东泰禾生物药业有限公司		Certificate Issued	2003-05-09	view
CZL01099	人参皂甙-Rd		Other	Chinese Herbal Medicine(1)	New Drug Application	2001-08-09	广东泰禾生物药业有限公司	Guangdong Taihe Biology Pharmaceutical Co Ltd	Certificate Issued	2003-09-27	view
CZL01100	人参皂甙-Rd注射液		Injection	Chinese Herbal Medicine(1)	New Drug Application	2001-08-09	广东泰禾生物药业有限公司	Guangdong Taihe Biology Pharmaceutical Co Ltd	Certificate Issued	2003-09-27	view
CXZB0600013	人参皂甙-Rd注射液		Injection	Chinese Herbal Medicine	Supplementary Application	2006-05-29	广东泰禾生物药业有限公司	Guangdong Taihe Biology Pharmaceutical Co Ltd;Guangzhou Zhongda Zhongshan Medical Technology Development Co Ltd	Certificate Issued	2007-11-01	view
CXSB1800002	注射用重组改构人肿瘤坏死因子	recombinant mutant human tumor necrosis factor	Lyophilized	Biological Products	Supplementary Application	2018-02-13	广东泰禾生物药业有限公司	Guangdong Taihe Biology Pharmaceutical Co Ltd	Certificate Issued	2019-03-26	view
CBSR1900001	注射用重组改构人肿瘤坏死因子	recombinant mutant human tumor necrosis factor	Lyophilized	Biological Products	State Standards	2019-04-22	广东泰禾生物药业有限公司	Guangdong Taihe Biology Pharmaceutical Co Ltd	Certificate Issued	2020-03-06	view